Downloading...
Download

Growth

XRP | Great TP Zone is HERE for HODLERSXRP has seen a 62% increase since breaking out above the moving averages in the daily timeframe. The previous time XRP broke out above the moving averages in the daily, the price increased around 440%: However, with XRP being the ultimate pumper and dumper, I'll take my chances at 62%! Because this bull run has been anything but ordinary and it's best to avoid being too greedy. The price of XRP falls extremely quick, just as quick as it rises.. ( Maybe not overnight but you know, it has happened before ). If you're one of few who bought around $1, or heck even later at $2, this is a solid increase and it should not be taken for granted. XRP has gone LONG periods without increases and often stayed behind making new ATH's when other cycles have come and gone (twice), as other alts make new ATH's. Over the years, I've made extensive posts on XRP; documented its use case, followed the SEC case closely and yet, XRP still remains one of the strangest and most unpredictable alts I have ever tried to analyze. Long term followers will remember that a I was bullish in 2018/2019 and then slowly became uninterested up until the point of negative towards XRP for probably the past 3-4 years. This is not only because of the lagging price compared to other older alts that soared like ETH and even Litecoin. Sure we did not see the growth and the taco stand ( who remembers ) just kept dumping on the market... But the entire "scandal" of the actors marketing/pimping, the dumping behind the scenes by executives to fund Ripple in early days, the lawsuit etc. was just such a colossal mess that I even wonder how XRP is still alive and kicking today. All I'm saying is that this is truly a spectacular moment - it's hard to even imagine cripple crossed $3 after years and years of waiting on XRP when other alts x1000% and beyond. Point being - Don't miss it! Trading only works when you take profits. ________________________ BINANCE:XRPUSDT
by Crypto-Check-
2
BTC TREASURY Adam Back, a satoshi era OG, is launching Bitcoin Standard Treasury Company (BSTR), which plans to go public through a merger with Cantor Equity Partners I (CEPO), a special-purpose acquisition company. BSTR will debut with 30,021 BTC, valued at approximately $3.5 billion, making it the fourth-largest public Bitcoin treasury. The company has secured $1.5 billion in private investment in public equity (PIPE) financing, the largest for a Bitcoin treasury SPAC merger, with CEPO contributing up to $200 million, subject to shareholder redemptions. The merger, expected to close in Q4 2025, aims to maximize Bitcoin ownership per share and accelerate adoption through Bitcoin-native financial products and advisory services. Ill be loading shares tommorrow and continuing to dca. Btc price swings will influence this heavily wind direction is currently North!
NASDAQ:CEPOLong
by WSMS199
A BNPL Bubble Is Actually Why I'm Bullish, For NowBNPL is growing and inflating at an increasing rate. From concert tickets to burritos, everyone is using buy now pay later. The global market is projected to hit 560 billion dollars in 2025, up from around 492 billion in 2024, and climb to 912 billion by 2030 at a compounding growth rate of 10.2%. Just in the U.S. alone, demand is expected to reach 122 billion next year and scale to 184 billion by the end of the decade. The trajectory is steep, with the structural weaknesses already showing. Block is positioned at the center of BNPL. In Q1 2025 they reported: 2.29 billion in gross profit, up 9 percent YoY 466 million in adjusted operating income, up 28% 10.3 billion in GMV through Afterpay, with 298 million in BNPL gross profit, up 23% YoY The stock took a hit. It dropped 9 percent in February and another 21 percent after missing Q1 earnings, but this is seen as typical early bubble behavior. There is short term fear but continuing growth and acceleration. Klarna’s credit losses, IPO delays, and regulatory friction are not problems, they are actually signals that the sector is growing faster than the market, or quite frankly, anyone can control. BNPL is becoming the default credit system for younger consumers. It is overused and expanding too fast. That is the formula for both upside and implosion. However with that, timing will be everything here, and knowing when to close will be crucial if BNPL can't stabilize. Baseline expectation: SQ trades in the 80 to 90 range in the short term Midterm upside: 120 by 2027 Long-term target: 180 to 220 if BNPL stabilizes and Block captures its runway
NYSE:XYZLong
by chrisapach
1
HUYA | HUYA | Long at $2.61HUYA NYSE:HUYA operates game live streaming platforms in China. This stock got my attention based on the reported fundamentals and price position, but moderate "Chinese delisting" risks exist given the US's new political administration. Book Value = $3.23 (Undervalued) Forward P/E = 4.1x (Growth) Debt-to-equity = 0x (Healthy) Quick Ratio = 1.56x (Healthy) Altman's Z Score = <1.8 (Bankruptcy risk is relatively high) From a technical analysis perspective, the stock price momentum has shifted upward based on the historical simple moving average. The price often consolidates within and slightly outside of this simple moving average band before progressing higher (after a long period of selling). While near term-declines are a risk, a longer-term hold (if the fundamentals do not change and delisting doesn't occur) may pay off given the value, growth, and overall health of the company. Thus, at $2.61, NYSE:HUYA is in a personal buy zone. Targets into 2028: $3.45 (+32.2%) $5.80 (+122.2%)
NYSE:HUYALong
by WorthlessViews
Elevance Health | ELV | Long at $286.00What are seeing in the healthcare and health insurance provider industry right now is destruction before a once-in-a-lifetime boom. The baby boomer generation is between 60 and 79 right now and the amount of healthcare service that will be needed to serve that population is staggering. Institutions are crushing them to get in - it's just near-term noise, in my opinion. My personal strategy is buy and hold every healthcare opportunity (i.e. NYSE:CNC , NYSE:UNH , NYSE:HUM etc). Elevance Health NYSE:ELV just dropped heavily due to lower-than-expected Q2 2025 earnings, a cut in full-year profit guidance from $34.15-$34.85 to ~$30 EPS, and elevated medical costs in Medicaid and ACA plans. It's near-term pain (may last 1-2 years) which will highly likely lead to long-term growth. The price has touched my historical simple moving average "crash" band. I would not be shocked to see the price drop further into the $260s before a rise. However, the near-term doom could go further into the year. I am anticipating another drop to the "major crash" simple moving average band into the $190s and $220s to close out the remaining price gaps on the daily chart that occurred during the COVID crash. Not to say it will absolutely reach that area, but it's locations on the chart I have for additional buys. Thus, at $286.00, NYSE:ELV is in a personal buy zone (starter position) with more opportunities to gather shares likely near $260 before a bounce. However, if the market or healthcare industry really turns, additional buys planned for $245 and $212 for a long-term hold. Targets into 2028: $335.00 (+17.1%) $386.00 (+35.0%)
NYSE:ELVLong
by WorthlessViews
Coca Cola to protect my portfolio and help it growOne of the most important things we must try to determine as investors is what company is the best at what they do in their field. In my opinion Coca Cola is and has always been the number one soft drink manufacturer, always finding new yet subtle ways to stay ahead of their competition. The reason I have allocated a decent amount of my portfolio to Coca Cola is a combination between their reliable track record of creating value, and paying dividends. People love junk food so it gives me high conviction to hold the stock long term. The company also demonstrates consistent, and reliable methods of generating organic revenue, and constantly finding new ways to cut costs and improve their profit margins. Despite what some other critics may claim about the stock being over valued, the intrinsic value of the stock happens to be $77 with a range between $48-$180. According to technical analysis it is over valued. I have too much respect for Coca Cola to trust technical analysis in my decision to hold the stock, I am rely solely on fundamentals. According to my perspective on the company it is in fact undervalued. Another positive catalyst I have noticed was when President Trump said he thinks Coca Cola should be made with cane sugar in the US, I think that would be a great idea, not only would it be healthier the soda would also taste better. Coca Cola looks like its going to stay ahead of the game for the foreseeable future.
NYSE:KOLong
by Capitalist_Zach
Dynemic Ltd: Bullish Setup UnfoldingDynemic Products Ltd (NSE: DYNPRO) is a well-established exporter and manufacturer of synthetic food-grade dyes, lake colors, and D&C colors, catering to global markets. As of July 16, 2025, the stock trades at ₹341 and has recently broken out of a prolonged consolidation zone, indicating renewed investor interest. From a fundamental perspective, the company’s financials show notable improvements: 🔸 Revenue (FY25): ₹214 crore, up 29% YoY 🔸 Net Profit (FY25): ₹15 crore, up 269% YoY 🔸 EPS (TTM): ₹3.65 🔸 P/E Ratio: ~23× – moderately valued 🔸 P/B Ratio: ~1.56× – near fair book value 🔸 ROE: ~7%, showing improving return to shareholders 🔸 ROCE: ~12.7%, indicating decent operational efficiency 🔸 Debt-to-Equity: ~0.43× – financially stable 🔸 Current Ratio: ~0.95× – slightly below ideal liquidity levels 🔸 Operating Cash Flow: ₹28 crore – healthy cash generation While the company has a stable balance sheet and growing profitability, investors should note that liquidity remains slightly tight, requiring careful monitoring of working capital and short-term obligations. Nonetheless, the financial turnaround and earnings consistency signal strength. On the technical front, the stock has shown strong bullish action after breaking above a multi-month resistance: 🔹 Breakout Zone Cleared: ₹325–₹330 (previous resistance) 🔹 Current Price: ₹341 🔹 Reversal Zone (Strong Support): ₹292 to ₹304 🔹 R1: ₹392 – short-term resistance 🔹 R2: ₹469 – medium-term target 🔹 R3: ₹615 – long-term upside if momentum sustains The breakout is confirmed with increased volume and a clear higher-high, higher-low structure, validating bullish sentiment. The price now rides above a rising trendline, suggesting trend continuation unless a breakdown occurs below ₹292. In summary, Dynemic Products Ltd currently offers a compelling techno-fundamental setup. The financials have improved significantly, valuations remain reasonable, and the technical breakout suggests potential for further upside. Investors can consider accumulating on dips above ₹304, while swing traders may target ₹392 and ₹469 in the short-to-medium term. A close watch on liquidity and cash flows is advised, but the stock presents a strong growth case in the specialty chemicals space. Disclaimer: lnkd.in
NSE:DYNPROLong
by ALICEBLUE
Raising the bar for SpotifySpotify has been my favorite stock so far this year. Primarily because resilience in uncertain economies. Subscription-based services, especially freemium models, are seen as defensive. Spotify is the number one music streaming service in the world and unless that changes people will keep using it every single day in their lives. They will generate revenues based on advertisements and subscriptions which are in my opinion reasonable and conducive of a strong business model. I am raising my price target to $985. This is not unreasonable considering the intrinsic value of the stock is between $400 and $2900. I am confident Spotify will find ways to stay ahead of its competitors and dominate the music streaming industry. While keeping its customers happy and loyal.
NYSE:SPOTLong
by Capitalist_Zach
Agilon Health | AGL | Long at $2.36Reentering this trade (original: ) Agilon Health NYSE:AGL Pros: Revenue consistently grew from 2019 ($794 million) to 2024 ($6.06 billion). Expected to reach $9.16 billion by 2028. Current debt-to-equity ratio 0.07 (very low) Sufficient cash reserves to fund operations and strategic initiatives Strong membership growth (659,000 in 2024, a 38% year-over-year increase) Recent insider buying ($2 - $3) and awarding of options Cons: Rising medical costs - currently unprofitable and not forecast to become profitable over the next 3 years Medicare Advantage Membership issues with the new political administration No dividend It's a gamble and I think it's a possibility this could drop near $1 in the near-term due to the Medicaid changes/fear... regardless, long-term, personal buy-zone at $2.36. Targets in 2027 $3.70 (+56.8%) $5.25 (+122.5%)
NYSE:AGLLong
by WorthlessViews
Why TSLA will Crash based On Copper TarrifsHere’s why that bearish outlook is gaining traction: Copper costs are surging: Tesla uses over 180 pounds of copper per vehicle. With prices spiking 13% in a single day and a 50% tariff looming, production costs are rising fast. Analysts are cutting price targets: UBS, JPMorgan, and Bank of America have all lowered their forecasts for Tesla, citing margin pressure and weakening demand3. Brand sentiment is shaky: Tesla’s recent delivery miss and political controversies around Elon Musk have added to investor unease. Tariff ripple effects: The broader trade war is expected to disrupt supply chains and inflate costs across the EV sector5. That said, some analysts still see long-term upside if Tesla can pivot quickly—especially with its AI and autonomous driving ambitions. But for now, the market is reacting to the immediate risks. Overall Enter Short for Gains of 3-5 percent.
NASDAQ:TSLAShort
by ChartKings
5
Figs Inc | FIGS | Long at $5.24Figs Inc $NYSE:FIGS. Technical analysis play first, fundamentals second. My selected historical simple moving average lines have converged with the stock price, which often leads to sideways trading and a reversal in the downward trend (i.e. future price increase). The downward trend is flattening, but that doesn't mean post-earnings drop to $1.50-$2.00 isn't out of the question... The FIGS brand is growing within the healthcare world with significant opportunities overseas. While economic headwinds may impede near/medium-term growth, revenue is anticipated to grow into 2027. EPS is expected to rise from 0.01 in 2024 to 0.20 by 2027. While this is not a "value" play and there is high risk for rug pulls, something may be brewing within the chart for a move up. Tread lightly, however... Targets $6.00 $6.40 $7.00 $8.00
NYSE:FIGSLong
by WorthlessViews
Applied Materials | AMAT | Long at $169.75Republican Ashley Moody recently dropped $200k-$500k on Applied Materials $NASDAQ:AMAT. The semiconductor boom may not be over... Price-to-earnings: 21.68x (great in comparison to others...) Debt-to-equity: 0.34x (low) Cash flow: $10.4 billion (FY2024) Insiders awarded options recently Unless NASDAQ:NVDA brings the market down, NASDAQ:AMAT is in a personal buy zone at $169.75. While the price may dip in the near-term to the $140s, bullish until the semi boom dies... Targets: $195.00 $215.00 $240.00
NASDAQ:AMATLong
by WorthlessViews
The Whale’s Blueprint: Read It Before It Happens🧠 The Real Game Institutional Bullish vs Institutional Bearish — It Was Never About Direction. This chart isn’t about setups. It’s a blueprint of manipulation, a battlefield map where: • Retail gets trapped at emotional highs • Liquidity gets swept in layers • Institutions reload in silence • And the price becomes the puppet, not the player 🔺 Top Red Zones (106K–112K): These aren’t resistance. They’re execution zones for sell walls, fake breakouts, and late long liquidations. 🔻 Green Demand Zones (105K & Below): Not support. They’re reaction chambers — where whales absorb panic and retail exits in fear. 💥 125K is not a fantasy. It’s a controlled explosion waiting to happen — But only if the trap is set right and the fuel (volume + interest) loads in. 🧱 Real accumulation doesn’t happen in comfort. It happens in the shadows, at the edges of fear. This isn’t price action. This is power action. ⸻ “Most trade the surface. Snipers wait beneath it… and strike before the story reveals itself.” #BTCUSDT #LiquidityGame #WhaleTrap #InstitutionalZones #SniperMindset #KaizenMethod #TheRealGame
by Yash_Panchal09
JD.cm | JD | Long at $33.16Like Amazon NASDAQ:AMZN and Alibaba NYSE:BABA , I suspect AI and robotics will enhance JD.com's NASDAQ:JD automation in warehousing, delivery, and retail. There is some risk here, like other Chinese stocks, that they could be delisted from the US market if trade/war tensions rise. But I just don't think that is likely (no matter the threats) due to the importance of worldwide trade and investment. I could be way wrong, though... NASDAQ:JD has a current P/E of 8.1x and a forward P/E of 1.2x, which indicates strong earnings growth ahead. The company is healthy, with a debt-to-equity of 0.4x, Altmans Z Score of 2.6, and a Quick Ratio of .9 (could be better). From a technical analysis perspective, the historical simple moving average (SMA) band is still in an overall downtrend but starting to level out (accumulation of share area). It is possible, however, that the price may drop into the $20s to close out the existing price gaps on the daily chart as tariff threats arise. But that area is another personal entry zone if fundamentals hold. Thus, while it could be a bumpy ride and the risk is there for delisting, NASDAQ:JD is in a personal buy zone at $33.16 (with known risk of drop to the $20s in the near-term). Targets into 2028: $44.00 (+32.7%) $52.00 (+56.8%)
NASDAQ:JDLong
by WorthlessViews